What is the next step in management for a 78-year-old female with recent Clostridioides difficile infection who has not improved after a 10‑day course of oral vancomycin?

Treatment Failure After 10 Days of Vancomycin for C. difficile

For this 78-year-old woman with persistent C. difficile infection after 10 days of vancomycin, switch to fidaxomicin 200 mg twice daily for 10 days as the preferred next step. 1

Rationale and Management Algorithm

This scenario represents either a first recurrence or non-response to initial therapy. The 2021 IDSA/SHEA guidelines clearly prioritize fidaxomicin for first recurrences, and this applies to treatment failures as well 1.

Preferred Treatment Options (in order):

1. Fidaxomicin 200 mg PO twice daily for 10 days 1

   • This is the guideline-recommended preferred agent for first recurrence
   • Can also use extended-pulsed regimen: twice daily for 5 days, then once every other day for 20 days 1

2. Vancomycin tapered and pulsed regimen (if fidaxomicin unavailable) 1

   • 125 mg 4 times daily × 10-14 days
   • Then 125 mg twice daily × 7 days
   • Then 125 mg once daily × 7 days
   • Then 125 mg every 2-3 days × 2-8 weeks

3. Standard vancomycin 125 mg 4 times daily × 10 days (least preferred) 1

Critical Considerations for This 78-Year-Old Patient:

Age-Related Factors:

• Elderly patients (>65 years) are at increased risk of nephrotoxicity with oral vancomycin 2
• Monitor renal function during and after treatment, even if baseline function was normal 2
• Older patients may take longer to respond to therapy (median 6 days vs 4 days in younger patients) 2
• Do not prematurely discontinue or switch therapy in elderly patients 2

Important Pitfalls to Avoid:

1. Do NOT simply repeat the same 10-day vancomycin course - this already failed and repeating it has lower success rates
2. Do NOT use metronidazole - it is not recommended for recurrent/refractory CDI 1
3. Assess for fulminant disease before choosing therapy:
   • Check for hypotension, ileus, megacolon, WBC >15,000, or creatinine >1.5 mg/dL
   • If fulminant: requires higher-dose vancomycin (500 mg 4 times daily) ± IV metronidazole ± rectal vancomycin 1

Adjunctive Therapy to Consider:

Bezlotoxumab 10 mg/kg IV × 1 dose during antibiotic treatment 1

• Monoclonal antibody against C. difficile toxin B
• Reduces recurrence risk
• Caution: Use carefully in patients with congestive heart failure 1

If This Represents a Second or Subsequent Recurrence:

If the patient has already had multiple episodes, additional options include 1:

• Vancomycin taper/pulse (as above)
• Vancomycin 125 mg 4 times daily × 10 days followed by rifaximin 400 mg 3 times daily × 20 days
• Fecal microbiota transplantation (FMT) - recommended after failure of at least 2 recurrences (i.e., 3 total CDI episodes) 1

Monitoring During Treatment:

• Renal function - particularly important in this elderly patient 2
• Clinical response (diarrhea frequency, abdominal pain)
• Expected median time to resolution: 4-6 days in elderly patients 2
• Be aware that recurrence rates remain 18-25% even after successful treatment 2

The evidence strongly supports fidaxomicin as superior to repeating standard vancomycin in this scenario, with the tapered/pulsed vancomycin regimen as the alternative if fidaxomicin is unavailable or unaffordable.